|
1
|
Bresci G: Portal hypertension: The
management of esophageal/gastric varices, portal hypertensive
gastropathy or hypertensive colopathy. Therapy. 4:91–96. 2007.
|
|
2
|
Mansour L, El-Kalla F, EL-Bassat H,
Abd-Elsalam S, El-Bedewy M, Kobtan A, Badawi R and Elhendawy M:
Randomized controlled trial of scleroligation versus band ligation
alone for eradication of gastroesophageal varices. Gastrointest
Endosc. 86:307–315. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sarin SK, Lahoti D, Saxena SP, Murthy NS
and Makwana UK: Prevalence, classification and natural history of
gastric varices: A long-term follow-up study in 568 portal
hypertension patients. Hepatology. 16:1343–1349. 1992.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Trudeau W and Prindiville T: Endoscopic
injection sclerosis in bleeding gastric varices. Gastrointest
Endosc. 32:264–268. 1986.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tripathi D, Stanley AJ, Hayes PC, Patch D,
Millson C, Mehrzad H, Austin A, Ferguson JW, Olliff SP, Hudson M,
et al: U.K. guidelines on the management of variceal haemorrhage in
cirrhotic patients. Gut. 64:1680–1704. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bosch J and García-Pagán JC: Prevention of
variceal rebleeding. Lancet. 361:952–954. 2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Brunner F, Berzigotti A and Bosch J:
Prevention and treatment of variceal haemorrhage in 2017. Liver
Int. 37 (Suppl 1):S104–S115. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gonzalez R, Zamora J, Gomez-Camarero J,
Molinero LM, Bañares R and Albillos A: Meta-analysis: Combination
endoscopic and drug therapy to prevent variceal rebleeding in
cirrhosis. Ann Intern Med. 149:109–122. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ravipati M, Katragadda S, Swaminathan PD,
Molnar J and Zarling E: Pharmacotherapy plus endoscopic
intervention is more effective than pharmacotherapy or endoscopy
alone in the secondary prevention of esophageal variceal bleeding:
A meta-analysis of randomized, controlled trials. Gastrointest
Endosc. 70:658–664.e5. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Garcia-Tsao G, Abraldes J, Berzigotti A
and Bosch J: Portal Hypertensive Bleeding in Cirrhosis: Risk
Stratification, Diagnosis, and Management: 2016 practice guidance
by the American association for the study of liver diseases.
Hepatology. 65:310–335. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Thiele M, Krag A, Rohde U and Gluud LL:
Meta-analysis: Banding ligation and medical interventions for the
prevention of rebleeding from oesophageal varices. Aliment
Pharmacol Ther. 35:1155–1165. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Puente A, Hernández-Gea V, Graupera I,
Roque M, Colomo A, Poca M, Aracil C, Gich I, Guarner C and
Villanueva C: Drugs plus ligation to prevent rebleeding in
cirrhosis: An updated systematic review. Liver Int. 34:823–833.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Funakoshi N, Ségalas-Largey F, Duny Y,
Oberti F, Valats JC, Bismuth M, Daurès JP and Blanc P: Benefit of
combination β-blocker and endoscopic treatment to prevent variceal
rebleeding: A meta-analysis. World J Gastroenterol. 16:5982–5992.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Garcia-Tsao G, Abraldes JG, Berzigotti A
and Bosch J: Portal hypertensive bleeding in cirrhosis: Risk
stratification, diagnosis, and management: 2016 practice guidance
by the American Association for the study of liver diseases.
Hepatology. 65:310–335. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
de Franchis R: BavenoV Faculty: Expanding
consensus in portal hypertension: Report of the Baveno VI Consensus
Workshop: stratifying risk and individualizing care for portal
hypertension. J Hepatol. 63:743–752. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen J, Zeng XQ, Ma LL, Huang XQ, Tseng
YJ, Wang J, Luo TC and Chen SY: Long-term efficacy of endoscopic
ligation plus cyanoacrylate injection with or without sclerotherapy
for variceal bleeding. J Dig Dis. 17:252–259. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rücker G and Schwarzer G: Ranking
treatments in frequentist network meta-analysis works without
resampling methods. BMC Med Res Methodol. 15(58)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Schwarzer G, Carpenter J and Rücker G:
Netmeta: Network meta-analysis with R (2016). R Package Version
0.9-2. netmeta, Cited February 22, 2016. Available from http://CRAN.R-project.org/package=netmeta.
|
|
19
|
Gupta V, Rawat R and Shalimar Saraya A:
Carvedilol versus propranolol effect on hepatic venous pressure
gradient at 1 month in patients with index variceal bleed: RCT.
Hepatol Int. 11:181–187. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sauerbruch T, Mengel M, Dollinger M,
Zipprich A, Rössle M, Panther E, Wiest R, Caca K, Hoffmeister A,
Lutz H, et al: Prevention of rebleeding from esophageal varices in
patients with cirrhosis receiving small-diameter stents versus
hemodynamically controlled medical therapy. Gastroenterology.
149:p. 660–688.e1. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Luo X, Wang Z, Tsauo J, Zhou B, Zhang H
and Li X: Advanced cirrhosis combined with portal vein thrombosis:
A randomized trial of TIPS versus endoscopic band ligation plus
propranolol for the prevention of recurrent esophageal variceal
bleeding. Radiology. 276:286–293. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kumar P, Saxena KN, Misra SP and Dwivedi
M: Secondary prophylaxis of variceal hemorrhage: A comparative
study of band ligation, carvedilol and propranolol plus isosorbide
mononitrate. Ind J Gastroenterology. 34(A54)2015.
|
|
23
|
Kong DR, Wang JG, Chen C, Yu FF, Wu Q and
Xu JM: Effect of intravariceal sclerotherapy combined with
esophageal mucosal sclerotherapy using small-volume sclerosant for
cirrhotic patients with high variceal pressure. World J
Gastroenterol. 21:2800–2806. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kumar A, Jha SK, Sharma P, Dubey S, Tyagi
P, Sharma BC and Sarin SK: Addition of propranolol and isosorbide
mononitrate to endoscopic variceal ligation does not reduce
variceal rebleeding incidence. Gastroenterology. 137:892–901.
2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sauer P, Hansmann J, Richter GM, Stremmel
W and Stiehl A: Endoscopic variceal ligation plus propranolol vs.
transjugular intrahepatic portosystemic stent shunt: A long-term
randomized trial. Endoscopy. 34:690–697. 2002.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gülberg V, Schepke M, Geigenberger G, Holl
J, Brensing KA, Waggershauser T, Reiser M, Schild HH, Sauerbruch T
and Gerbes AL: Transjugular intrahepatic portosystemic shunting is
not superior to endoscopic variceal band ligation for prevention of
variceal rebleeding in cirrhotic patients: A randomized, controlled
trial. Scand J Gastroenterol. 37:338–343. 2002.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Escorsell A, Bañares R, García-Pagán JC,
Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados
A and Bosch J: TIPS versus drug therapy in preventing variceal
rebleeding in advanced cirrhosis: A randomized controlled trial.
Hepatology. 35:385–392. 2002.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Villanueva C, Miñana J, Ortiz J, Gallego
A, Soriano G, Torras X, Sáinz S, Boadas J, Cussó X, Guarner C and
Balanzó J: Endoscopic ligation compared with combined treatment
with nadolol and isosorbide mononitrate to prevent recurrent
variceal bleeding. N Engl J Med. 345:647–655. 2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pomier-Layrargues G, Villeneuve JP,
Deschênes M, Bui B, Perreault P, Fenyves D, Willems B, Marleau D,
Bilodeau M, Lafortune M and Dufresne MP: Transjugular intrahepatic
portosystemic shunt (TIPS) versus endoscopic variceal ligation in
the prevention of variceal rebleeding in patients with cirrhosis: A
randomised trial. Gut. 48:390–396. 2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Narahara Y, Kanazawa H, Kawamata H, Tada
N, Saitoh H, Matsuzaka S, Osada Y, Mamiya Y, Nakatsuka K, Yoshimoto
H, et al: A randomized clinical trial comparing transjugular
intrahepatic portosystemic shunt with endoscopic sclerotherapy in
the long-term management of patients with cirrhosis after recent
variceal hemorrhage. Hepatol Res. 21:189–198. 2001.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hou MC, Chen WC, Lin HC, Lee FY, Chang FY
and Lee SD: A new ‘sandwich’ method of combined endoscopic variceal
ligation and sclerotherapy versus ligation alone in the treatment
of esophageal variceal bleeding: A randomized trial. Gastrointest
Endosc. 53:572–578. 2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Meddi P, Merli M, Lionetti R, De Santis A,
Valeriano V, Masini A, Rossi P, Salvatori F, Salerno F, de Franchis
R, et al: Cost analysis for the prevention of variceal rebleeding:
A comparison between transjugular intrahepatic portosystemic shunt
and endoscopic sclerotherapy in a selected group of Italian
cirrhotic patients. Hepatology. 29:1074–1077. 1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
García-Villarreal L, Martínez-Lagares F,
Sierra A, Guevara C, Marrero JM, Jiménez E, Monescillo A,
Hernández-Cabrero T, Alonso JM and Fuentes R: Transjugular
intrahepatic portosystemic shunt versus endoscopic sclerotherapy
for the prevention of variceal rebleeding after recent variceal
hemorrhage. Hepatology. 29:27–32. 1999.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sauer P, Theilmann L, Stremmel W, Benz C,
Richter G and Stiehl A: Transjugular intrahepatic portosystemic
stent shunt versus sclerotherapy plus propranolol for variceal
rebleeding. Gastroenterology. 113:1623–1631. 1997.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sanyal AJ, Freedman AM, Luketic VA, Purdum
PP III, Shiffman ML, Cole PE, Tisnado J and Simmons S: Transjugular
intrahepatic portosystemic shunts compared with endoscopic
sclerotherapy for the prevention of recurrent variceal hemorrhage.
a randomized, controlled trial. Ann Intern Med. 126:849–857.
1997.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Villanueva C, Balanzó J, Novella MT,
Soriano G, Sáinz S, Torras X, Cussó X, Guarner C and Vilardell F:
Nadolol plus isosorbide mononitrate compared with sclerotherapy for
the prevention of variceal rebleeding. N Engl J Med. 334:1624–1629.
1996.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Li P, Kong RD, Xie HJ, Sun B and Xu JM:
Efficacy and safety of endoscopic variceal ligation and endoscopic
injection sclerotherapy in patients with cirrhosis and esophageal
varices: A prospective study. World Chinese J Digestology.
18:3791–3795. 2010.
|
|
38
|
Holster IL, Tjwa E, Moelker A, Wils A,
Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ,
Kuipers EJ, et al: Covered transjugular intrahepatic portosystemic
shunt versus endoscopic therapy+β-blocker for prevention of
variceal rebleeding. Hepatology. 63:581–589. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
van Buuren HR, Groeneweg M, Vleggaar FP,
Lesterrhuis W, Van Tillburg AJP, Hop WCJ, Peiterman H, Schalam SW,
van Hout BA and Lameris JS: The results of a randomized controlled
trial evaluating TIPS and endoscopic therapy in cirrhotic patients
with gastro-esophageal variceal bleeding. J Hepatol.
32(71)2000.
|
|
40
|
Cabrera J, Maynar M, Granados R, Gorriz E,
Reyes R, Pulido-Duque JM, Rodriguez SanRoman JL, Guerra C and
Kravetz D: Transjugular intrahepatic portosystemic shunt versus
sclerotherapy in the elective treatment of variceal hemorrhage.
Gastroenterology. 110:832–839. 1996.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Dobrucali A, Bal K, Tuncer M, Ilkova F,
Çelik A, Uzunismail H, Yurdakul I and Oktay E: Endoscopic banding
ligation compared with sclerotherapy for the treatment of
esophageal varies. Turk J Gastroenterol. 9:340–344. 1998.
|
|
42
|
Holster IL, Moelker A, Tjwa ET, et al:
Early transjugular intrahepatic portosystemic shunt (TIPS) as
compared to endoscopic treatment reduces rebleeding but not
mortality in cirrhotic patients with a 1st or 2nd episode of
variceal bleeding: A multicentre randomized controlled trial.
United European Gastroenterology Journal. 1(A84)2013.
|
|
43
|
Merli M, Riggio O, Capocaccia L, et al:
TIPS vs sclerotherapy in preventing variceal rebleeding in
cirrhotic patients: Preliminary results of a randomised controlled
trial (EASL abstract). Journal of hepatology. 21(S41)1994.
|
|
44
|
Ahmad I, Khan AA, Alam A, Butt AK, Shafqat
F and Sarwar S: Propranolol, isosorbide mononitrate and endoscopic
band ligation-alone or in varying combinations for the prevention
of esophageal variceal rebleeding. J Coll Physicians Surg Pak.
19:283–286. 2009.PubMed/NCBI
|
|
45
|
Argonz J, Kravetz D, Suarez A, Romero G,
Bildozola M, Passamonti M, Valero J and Terg R: Variceal band
ligation and variceal band ligation plus sclerotherapy in the
prevention of recurrent variceal bleeding in cirrhotic patients: A
randomized, prospective and controlled trial. Gastrointest Endosc.
51:157–163. 2000.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Avgerinos A, Armonis A, Manolakopoulos S,
Poulianos G, Rekoumis G, Sgourou A, Gouma P and Raptis S:
Endoscopic sclerotherapy versus variceal ligation in the long-term
management of patients with cirrhosis after variceal bleeding. A
prospective randomized study. J Hepatol. 26:1034–1341.
1997.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Avgerinos A, Armonis A, Stefanidis G,
Mathou N, Vlachogiannakos J, Kougioumtzian A, Triantos C,
Papaxoinis C, Manolakopoulos S, Panani A and Raptis SA: Sustained
rise of portal pressure after sclerotherapy, but not band ligation,
in acute variceal bleeding in cirrhosis. Hepatology. 39:1623–1630.
2004.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Avgerinos A, Rekoumis G, Klonis C,
Papadimitriou N, Gouma P, Pournaras S and Raptis S: Propranolol in
the prevention of recurrent upper gastrointestinal bleeding in
patients with cirrhosis undergoing endoscopic sclerotherapy. A
randomized controlled trial. J Hepatol. 19:301–311. 1993.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Baroncini D, Milandri GL, Borioni D,
Piemontese A, Cennamo V, Billi P, Dal Monte PP and D'Imperio N: A
prospective randomized trial of sclerotherapy versus ligation in
the elective treatment of bleeding esophageal varices. Endoscopy.
29:235–240. 1997.PubMed/NCBI View Article : Google Scholar
|
|
50
|
García-Pagán JC, Villanueva C, Albillos A,
Bañares R, Morillas R, Abraldes JG and Bosch J: Spanish Variceal
Bleeding Study Group: Nadolol plus isosorbide mononitrate alone or
associated with band ligation in the prevention of recurrent
bleeding: A multicentre randomised controlled trial. Gut.
58:1144–1150. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Hou MC, Lin HC, Kuo BI, Chen CH, Lee FY
and Lee SD: Comparison of endoscopic variceal injection
sclerotherapy and ligation for the treatment of esophageal variceal
hemorrhage: A prospective randomized trial. Hepatology.
21:1517–1522. 1995.PubMed/NCBI
|
|
52
|
Hou MC, Lin HC, Lee FY, Chang FY and Lee
SD: Recurrence of esophageal varices following endoscopic reagent
and impact on rebleeding: Comparison of sclerotherapy and ligation.
J Hepatology. 32:202–208. 2000.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF,
Chen SM and Chiang HT: A prospective, randomized trial of
sclerotherapy versus ligation in the management of bleeding
esophageal varices. Hepatology. 22:466–4671. 1995.PubMed/NCBI
|
|
54
|
Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS,
Hsu PI and Chiang HT: Emergency banding ligation versus
sclerotherapy for the control of active bleeding from esophageal
varices. Hepatology. 25:1101–1104. 1997.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Peña J, Brullet E, Sanchez-Hernández E,
Rivero M, Vergara M, Martin-Lorente JL and Garcia Suárez C:
Variceal ligation plus nadolol compared with ligation for
prophylaxis of variceal rebleeding: A multicenter trial.
Hepatology. 41:572–578. 2005.PubMed/NCBI View Article : Google Scholar
|
|
56
|
de la Peña J, Rivero M, Sanchez E, Fábrega
E, Crespo J and Pons-Romero F: Variceal ligation compared with
endoscopic sclerotherapy for variceal hemorrhage: Prospective
randomized trial. Gastrointest Endosc. 49:417–423. 1999.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Romero G, Kravetz D, Argonz J, Vulcano C,
Suarez A, Fassio E, Dominguez N, Bosco A, Muñoz A, Salgado P and
Terg R: Comparative study between nadolol and 5-isosorbide
mononitrate vs. Endoscopic band ligation plus sclerotherapy in the
prevention of variceal rebleeding in cirrhotic patients: A
randomized controlled trial. Aliment Pharmacol Ther. 24:601–611.
2006.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Stiegmann GV, Goff JS, Michaletz-Onody PA,
Korula J, Lieberman D, Saeed ZA, Reveille RM, Sun JH and Lowenstein
SR: Endoscopic sclerotherapy as compared with endoscopic ligation
for bleeding esophageal varices. N Engl J Med. 326:1527–1532.
1992.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Umehara M, Onda M, Tajiri T, Toba M,
Yoshida H and Yamashita K: Sclerotherapy plus ligation versus
ligation for the treatment of esophageal varices: A prospective
randomized study. Gastrointest Endosc. 50:7–12. 1999.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Viazis N, Armonis A, Vlachogiannakos J,
Rekoumis G, Stefanidis G, Papadimitriou N, Manolakopoulos S and
Avgerinos A: Effects of endoscopic variceal treatment on
oesophageal function: a prospective, randomized study. Eur J
Gastroenterol Hepatol. 14:263–269. 2002.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Vinel JP, Lamouliatte H, Cales P, Combis
JM, Roux D, Desmorat H, Pradere B, Barjonet G and Quinton A:
Propranolol reduces the rebleeding rate during endoscopic
sclerotherapy before variceal obliteration. Gastroenterology.
102:1760–173. 1992.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zheng M, Chen Y, Bai J, Zeng Q, You J, Jin
R, Zhou X, Shen H, Zheng Y and Du Z: Transjugular intrahepatic
portosystemic shunt versus endoscopic therapy in the secondary
prophylaxis of variceal rebleeding in cirrhotic patients:
meta-analysis update. J Clin Gastroenterol. 42:507–516.
2008.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Chinese Society of Gastroenterology,
Chinese Medical Association, Chinese Society of Endoscopy:
Guidelines for the diagnosis and treatment of esophageal and
gastric variceal bleeding in cirrhotic portal hypertension. Chinese
Society of Hepatology, Chinese Medical Association. Chinese Medial
Association. J Clin Hepatol 32: 203-219, 2016 (In Chinese).
|
|
64
|
Cotoras P, Faundez J and Candia R: Should
we add beta-blockers to band ligation for secondary prophylaxis of
variceal bleeding? Medwave. 17 (Suppl 1)(e6847)2017.PubMed/NCBI View Article : Google Scholar
|
